Bethesda Pediatrics provides affordable healthcare thanks to East Texas Giving Day
Bethesda Health Clinic shares services they offer
'Last year, our generous community gifted us over $100,000 on East Texas Giving Day, which was so amazing and humbling,' Medical Director of Bethesda Pediatrics Danny Price said.
East Texas Giving Day donations from 2024 allowed Bethesda Health Clinic in Tyler to see and take care of East Texas patients who are uninsured or underinsured. Bethesda Clinic medical director Danni Price said the gift of donations is what helps keep the place running.
'It's literally the gifts and donations of our local friends that keep our lights on and pay our bills,' Price said.
East Texas Giving Day funds allow Bethesda to see patients in their pediatric and adult clinics while also offering counseling and dental visits.
'This year, we've set our sights higher at 150,000,' Price said. 'We really think that we can do that thanks to a $50,000 match.'
These funds also allow Bethesda to have more resources to help their patients, but East Texas Giving Day isn't just helping at the clinic, it's helping more than 362 local organizations.
'What we've seen year in and year out is our nonprofits really appreciate the opportunity to participate in this,' President and CEO of East Texas Communities Foundation Kyle Penney said. 'And it allows them to attract people that no other type of event can allow them to attract.'
While giving can normally be a private or quiet event, East Texas Giving Day asks everyone to share their contributions.
2025 East Texas Giving Day: Bethesda Health Clinic
'It's that viral nature of a giving event like this that helps introduce new people to charities they've never heard about before and allows them opportunity to support them as well,' Penney said.
East Texans sharing their donations is important for East Texas Giving Day so people can go to their website and learn about the different organizations in the area, like Bethesda Health Clinic.
'It's really been an amazing thing to see how generous and supportive our Tyler and East Texas community is,' Price said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
a day ago
- Forbes
Trump Is Making Healthcare A Winning '80/20' Political Issue For GOP
Cell lines are prepared in the laboratory of Dr. John Tisdale, a Senior Investigator at the National Heart, Lung, and Blood Institute's Cellular and Molecular Therapeutics Laboratory, at the National Institutes of Health in Bethesda, Maryland. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images) AFP via Getty Images President Trump has pledged to provide Americans with a vastly reformed healthcare system that's affordable, innovative and elevates patient care above anywhere else in the world. Despite the political shell games being played by liberal Democrats, the media and even some Republicans, much of President Trump's policy agenda has broad public support and is largely on track to succeed if enacted. For example, recent polling from McLaughlin & Associates shows well over 85% of likely voters favor his policy to bypass costly middlemen fees by allowing direct sales of medicines to patients. Across the board, his policies—from requiring foreign countries to pay their fair share for U.S. medical innovations, to securing unprecedented domestic drug manufacturing investments in the face of emerging threats from China, to ensuring Pharmacy Benefit Manager (PBM) corporations can't pocket large drug discounts meant for patients—have approval ratings of 80% or more. Who would've thought Donald Trump could make healthcare an '80/20' political issue for conservatives? The bigger question, however, is whether congressional Republicans, long considered disadvantaged among voters on the issue, will embrace his agenda and help pass it. Make no mistake, the opportunity is directly in front of them. Most Americans would probably agree that no one would design a healthcare system that looks anything like the one we have. It's confusing, rife with red tape, waste, fraud and abuse, manipulated by corporate middlemen and is far too expensive for patients, employers and taxpayers to sustain. At the same time, however, the U.S. system develops, manufactures and delivers the most cutting-edge medical treatments in the world. It doesn't add up that America can be at the forefront of innovation and investment, while drowning in antiquated systems that bankrupt families and fleece taxpayers of billions of dollars. These are complicated problems that too often have led to overly complicated and often self-serving politically directed policies that have made problems far worse for patients and families. President Joe Biden's changes to Medicare—part of the Democrats' ridiculously named Inflation Reduction Act (IRA) spending bill—are a perfect recent example. In addition to raiding billions of dollars in so-called Medicare savings to fund unrelated subsidies for big insurers, electric vehicle buyers and other special interests, the IRA's drug-price control measures led to massive premium spikes, kicked countless seniors off their Part D drug plans and stifled needed R&D investments in new cures and cutting-edge medicines. To be fair, President Trump has also threatened the use of heavy-handed price controls on prescription drugs. However, his aggregate policy proposals, which call for greater accountability, competition and transparency in healthcare—along with the force of nature he brings to the negotiating process—are set to achieve even greater results, to the point of making such price controls unnecessary. We should assume he knows this because during his first four years in office increases in drug prices remained at historic lows. Only eight months into his second term, President Trump has already applied unprecedented pressure on foreign governments to pay their fair share for U.S. drug innovations, worked to expose and rein in costly insurer middlemen and helped secure a record $300 billion in new domestic pharmaceutical R&D manufacturing and workforce investments. In short, President Trump is proving to be the ultimate price control in healthcare. And he's doing it without actually implementing such unnecessary measures—and he shouldn't—thus avoiding the negative access and innovation-killing impacts they'd have on patients, families, innovators and workers. Additionally, there are several other Trump-aligned policies being considered to help move America forward. They include requiring other countries to set NATO-like investment thresholds to ensure the U.S. doesn't bear the world's costs for medical innovation, expediting FDA reviews for lower-cost prescription drug and leveraging AI to power accelerated innovation discoveries and root out waste fraud and abuse. Taken together, these '80/20' healthcare proposals and other free-market reforms serve as the foundation of the 'Most Favored Patient' project (I'm one of the principals) [ a Trump-aligned agenda made up of commonsense solutions and innovative policies to address the everyday healthcare problems and costs impacting nearly every family. Now, thanks to President Trump, Republicans in Congress have a unique opportunity and platform to turn an issue that has historically been viewed as a primary weakness into a winning agenda that appeals to all American patients, taxpayers and voters. Here's some advice: Don't hesitate.
Yahoo
07-08-2025
- Yahoo
Hinge Health price target raised to $62 from $48 at Truist
Truist raised the firm's price target on Hinge Health (HNGE) to $62 from $48 and keeps a Buy rating on the shares, updating the firm's model after the company's Q2 results and guidance. The company's robust outcomes data, extensive partner network, AI-enabled platform, and compelling economics create a flywheel of adoption, retention, and expansion, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on HNGE: Disclaimer & DisclosureReport an Issue Hinge Health price target raised to $63 from $55 at Stifel Video: Disney, McDonald's and Uber headline busy earnings slate Hinge Health price target raised to $64 from $42 at BofA Hinge Health price target raised to $57 from $46 at Morgan Stanley Hinge Health price target raised to $61 from $52 at Canaccord Sign in to access your portfolio
Yahoo
03-08-2025
- Yahoo
Singer Jessie J returned to hospital with ‘infection' and ‘fluid on my lungs'
Singer Jessie J has revealed she returned to hospital where an 'infection' and 'a little fluid' on her lungs were discovered. The 37-year-old, whose real name is Jessica Cornish, said she has since discharged herself from the hospital where she was treated after breast cancer surgery just weeks ago, revealing in July that she had since seen 'no cancer spread'. In a post on Instagram, the Price Tag singer said: 'Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned. 'I had and still have symptoms that pointed towards a blood clot on the lung, it is not a blood clot thank god. 'They ran a lot of tests, which ended up showing I have an infection (still trying to figure out what) and a little fluid on my lungs. 'Finding it hard to breathe in, but I discharged myself last night (I hate being in hospital) and will continue the investigation as an outpatient.' She went on to say it was 'frustrating' that her career plans had to change due to her surgery and hospital visits, and added that she had been 'working so hard to get to this point and excited to do it all'. Cornish said: 'I know for me, the true hard journey of this whole thing physically was the day I went into surgery. 'The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me, especially as a mum with a toddler and being unable to be the mother I usually am.' The star said her visit to hospital was a 'reminder to myself to slow down' even though she felt she was already at a slow pace. Cornish added: 'This isn't a speedy recovery and it isn't meant to be. 'As an ADHD Aries, fire breathing dragon t-rex, I can do it myself, I'm always ok woman. That slow pace has been a hard reality to accept to be honest. 'I love moving and working and being up and active but I can't be right now, and that's what it is, and I am finding the strength knowing that all can be adjusted to align with a slower pace and the support of my very small inner support circle.' The London-born singer welcomed her son, Sky Safir Cornish Colman, in 2023, having had a miscarriage in November 2021. She has battled with ill-health throughout her life, having been diagnosed with a heart condition aged eight, suffering a minor stroke aged 18 and having briefly gone deaf in 2020. The singer-songwriter has had three number one songs in the UK singles chart with Domino, Price Tag and Bang Bang. She was awarded four Mobo awards in 2011 including best UK act, best newcomer, best song for Do It Like A Dude and best album with Who You Are, and won the Brit Award for rising star in 2011.
